Compound Libraries
Compound libraries are collections of stored compounds that are widely used to efficiently identify molecules of interest. These libraries are essential tools in research and development, especially in the search for new drugs, as they enable thorough screenings and quality controls to be conducted efficiently. Compound libraries are useful for conducting highly demanding analyses, significantly reducing the cost and time associated with these processes. At CymitQuimica, we offer an extensive range of high-quality compound libraries designed to meet the research and development needs in various scientific and industrial areas. Our catalog includes libraries with a wide variety of compounds, facilitating the identification and development of molecules with therapeutic potential and other innovative applications.
Products of "Compound Libraries"
Sort by
Rare Natural Product Library
A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);Color and Shape:Odour SolidRef: TM-L6900
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireAnti-Tumor Natural Product Library
A unique collection of 1772 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);Color and Shape:Odour SolidRef: TM-L6700
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireToxic Compound Library
A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS);Color and Shape:Odour SolidRef: TM-L5500
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireCardiotoxicity Compound Library
A unique collection of 131 cardiotoxicity inducing compounds for toxicological study;Color and Shape:Odour SolidRef: TM-L4900
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireMacrocyclic Compound Library
210 macrocyclic compounds of known activity for high-throughput, high-content screening;Color and Shape:Odour SolidRef: TM-L9300
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireBioactive Compound Library
A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, andColor and Shape:Odour SolidRef: TM-L4000
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireTyrosine Kinase Inhibitor Library
A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase relatedColor and Shape:Odour SolidRef: TM-L2200
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireGinsenoside Rb3
CAS:Ginsenoside Rb3 has anti-myocardial ischemia-reperfusion injury, neuroprotective, antidepressant-like, and antioxidant effects, it also possesses the potential of the clinical use in preventing and treating diabetes. Ginsenoside Rb3 significantly attenuates the changes of creatine kinase activity and lactate dehydrogenase activity, exhibits inhibitory effect on TNFα-induced NF-κB transcriptional activity with an IC50 of 8.2 μM in 293T cell lines, it also inhibits the induction of COX-2 and iNOS mRNA.Formula:C53H90O22Purity:95%~99%Molecular weight:1079.28Anti-Cardiovascular Disease Compound Library
A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);Color and Shape:Odour SolidRef: TM-L5400
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquire20(R)-Ginsenoside Rh2
CAS:Ginsenoside Rh2 is one of the most active components of red ginseng, controlling cancer and other metabolic diseases including osteoclast differentiation; ginsenoside Rh2 can suppress RANKL-induced osteoclast differentiation in vitro and in vivo through the regulation of c-Fos and NFATc1 expressions, not excluding the involvement of NF-κB and ERK, it is also suggested to be developed as a therapeutic drug for prevention and treatment of osteoporosis.Formula:C36H62O8Purity:20%, 95%, 98%Molecular weight:622.873Natural Product Derivatives Library
The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold).Color and Shape:Odour SolidAnti-Hypertension Compound Library
678 hypertension-related small molecules for high-throughput and high-content screening.Color and Shape:Odour SolidRef: TM-L7110
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireNucleotide Compound Library
A unique collection of 334 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-Color and Shape:Odour SolidRef: TM-L1720
1mgTo inquire50µl*10 (DMSO)3,064.00€30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireAntibiotics Library
A unique collection of 692 compounds with antibiotic activity for new antibacterial drug screening;Color and Shape:Odour SolidRef: TM-L4400
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquire
